Sex Differences in the Preventive Effect of Cardiovascular and Metabolic Therapeutics on Dementia
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sex Differences in the Preventive Effect of Cardiovascular and Metabolic Therapeutics on Dementia
Authors
Keywords
-
Journal
Biomolecules & Therapeutics
Volume 31, Issue 6, Pages 583-598
Publisher
The Korean Society of Applied Pharmacology
Online
2023-10-30
DOI
10.4062/biomolther.2023.115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lecanemab trial in AD brings hope but requires greater clarity
- (2023) Madhav Thambisetty et al. Nature Reviews Neurology
- FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
- (2023) Antoine Verger et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Exenatide exerts a neuroprotective effect against diabetic cognitive impairment in rats by inhibiting apoptosis: Role of the JNK/c‑JUN signaling pathway
- (2022) Gengyin Wang et al. Molecular Medicine Reports
- “Aducanumab” making a comeback in Alzheimer’s disease: An old wine in a new bottle
- (2022) Tapan Behl et al. BIOMEDICINE & PHARMACOTHERAPY
- Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab
- (2022) Mingchao Shi et al. Frontiers in Aging Neuroscience
- Sex Differences in Demographic and Pharmacological Factors in Alzheimer Patients With Dementia and Cognitive Impairments
- (2022) Oreoluwa O. Coker-Ayo et al. Frontiers in Behavioral Neuroscience
- Comparison of Benzbromarone and Allopurinol on Primary Prevention of the First Gout Flare in Asymptomatic Hyperuricemia
- (2022) Shih-Wei Lai et al. Journal of Personalized Medicine
- The Trend of Organic Based Nanoparticles in the Treatment of Diabetes and Its Perspectives
- (2022) Vijayakumar Natesan et al. Biomolecules & Therapeutics
- Association Between Use of Anti-gout Preparations and Dementia: Nested Case–Control Nationwide Population-Based Cohort Study
- (2021) Tsung-Ju Chuang et al. Frontiers in Medicine
- Aspirin Use on Incident Dementia and Mild Cognitive Decline: A Systematic Review and Meta-Analysis
- (2021) Hui Li et al. Frontiers in Aging Neuroscience
- Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non‐Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population‐Based Cohort Study
- (2021) Jin‐Yi Hsu et al. Journal of the American Heart Association
- Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis
- (2021) Jean K. Ho et al. HYPERTENSION
- Aducanumab: The first targeted Alzheimer's therapy
- (2021) Pan Yang et al. Drug Discoveries and Therapeutics
- Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies
- (2021) Elena Olmastroni et al. European Journal of Preventive Cardiology
- Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study
- (2020) Sieta T. de Vries et al. DRUG SAFETY
- Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study
- (2020) Francesco Vadini et al. INTERNATIONAL JOURNAL OF OBESITY
- Gender Differences in Cardiovascular Pharmacotherapy—the Example of Hypertension: A Mini Review
- (2020) Jacklean Kalibala et al. Frontiers in Pharmacology
- The Role of Leptin in the Association between Obesity and Psoriasis
- (2020) Jaehyeon Hwang et al. Biomolecules & Therapeutics
- Age, Sex, and Depot‐Specific Differences in Adipose‐Tissue Estrogen Receptors in Individuals with Obesity
- (2020) Jay W. Porter et al. Obesity
- Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study
- (2020) Katherine Samaras et al. DIABETES CARE
- Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation
- (2020) Daehoon Kim et al. EUROPACE
- Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study
- (2020) I. Kalar et al. JOURNAL OF INTERNAL MEDICINE
- Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease
- (2020) Gabriella Marucci et al. NEUROPHARMACOLOGY
- Sex-specific associations between lipids and cognitive decline in the middle-aged and elderly: a cohort study of Chinese adults
- (2020) Lili Liu et al. Alzheimers Research & Therapy
- Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease
- (2019) Dan-Dan Li et al. Frontiers in Neuroscience
- Pharmacological Potential of Cilostazol for Alzheimer’s Disease
- (2019) Kenjiro Ono et al. Frontiers in Pharmacology
- Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort
- (2019) Dongmin Kim et al. EUROPEAN HEART JOURNAL
- Stroke and dementia risk in patients with and without atrial fibrillation and carotid arterial disease
- (2019) T. Jared Bunch et al. HEART RHYTHM
- A pilot study of exenatide actions in Alzheimer’s disease
- (2019) Roger J. Mullins et al. Current Alzheimer Research
- Association between Use of Statin and Risk of Dementia: A Meta-Analysis of Observational Studies
- (2019) Tahmina Nasrin Poly et al. NEUROEPIDEMIOLOGY
- Gout
- (2019) Nicola Dalbeth et al. Nature Reviews Disease Primers
- Sex differences in metabolic regulation and diabetes susceptibility
- (2019) Blandine Tramunt et al. DIABETOLOGIA
- Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical Trial
- (2019) Chisa Matsumoto et al. DIABETES CARE
- Anti-Amyloid-β Monoclonal Antibodies for Alzheimer’s Disease: Pitfalls and Promise
- (2018) Christopher H. van Dyck BIOLOGICAL PSYCHIATRY
- Sex and Gender Differences in the Brain Cholinergic System and in the Response to Therapy of Alzheimer Disease with Cholinesterase Inhibitors
- (2018) Giacobini Ezio et al. Current Alzheimer Research
- Effect of Cilostazol on Incident Dementia in Elderly Men and Women with Ischemic Heart Disease
- (2018) Mi-Young Kim et al. JOURNAL OF ALZHEIMERS DISEASE
- The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
- (2018) Andre F Batista et al. JOURNAL OF PATHOLOGY
- Sex Differences in the Associations Between Lipid Levels and Incident Dementia
- (2018) Marie-Laure Ancelin et al. JOURNAL OF ALZHEIMERS DISEASE
- Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
- (2018) Tze Pin Ng et al. JOURNAL OF ALZHEIMERS DISEASE
- Cardiovascular benefits of acarbose versus sulfonylureas in type 2 diabetic patients treated with metformin
- (2018) Pai-Feng Hsu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study
- (2018) Delia Colombo et al. JOURNAL OF WOMENS HEALTH
- Sex differences in Alzheimer’s disease and common neuropathologies of aging
- (2018) Shahram Oveisgharan et al. ACTA NEUROPATHOLOGICA
- The association of multiple anti-hypertensive medication classes with Alzheimer’s disease incidence across sex, race, and ethnicity
- (2018) Douglas Barthold et al. PLoS One
- Gout and dementia in the elderly: a cohort study of Medicare claims
- (2018) Jasvinder A. Singh et al. BMC Geriatrics
- Effects of pioglitazone on the incidence of dementia in patients with diabetes
- (2017) Ping-Song Chou et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Serum glucose, cholesterol and blood pressure levels in Japanese type 1 and 2 diabetic patients: BioBank Japan
- (2017) Hiroshi Yokomichi et al. JOURNAL OF EPIDEMIOLOGY
- Weight Gain in Women at Midlife: A Concise Review of the Pathophysiology and Strategies for Management
- (2017) Ekta Kapoor et al. MAYO CLINIC PROCEEDINGS
- Female sex, early-onset hypertension, and risk of dementia
- (2017) Paola Gilsanz et al. NEUROLOGY
- Sex and gender differences in the treatment of Alzheimer’s disease: A systematic review of randomized controlled trials
- (2017) Marco Canevelli et al. PHARMACOLOGICAL RESEARCH
- Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease
- (2017) Julie M. Zissimopoulos et al. JAMA Neurology
- Amlodipine treatment of hypertension associates with a decreased dementia risk
- (2016) Leonid Feldman et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
- (2016) Rune V. Overgaard et al. CLINICAL PHARMACOKINETICS
- Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia
- (2016) Jennifer Y.Y. Szeto et al. Current Neuropharmacology
- Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension
- (2016) Yi-Chun Kuan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A 10-year follow-up study of the association between calcium channel blocker use and the risk of dementia in elderly hypertensive patients
- (2016) Chia-Liang Wu et al. MEDICINE
- Diuretics in the treatment of hypertension
- (2016) Douglas L. Blowey PEDIATRIC NEPHROLOGY
- Mean Daily Dosage of Aspirin and the Risk of Incident Alzheimer’s Dementia in Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study in Taiwan
- (2016) Cheng-Wei Chang et al. Journal of Diabetes Research
- Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia
- (2015) Saion Chatterjee et al. DIABETES CARE
- Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC: Figure 1
- (2015) Giuseppe M.C. Rosano et al. EUROPEAN HEART JOURNAL
- Global epidemiology of gout: prevalence, incidence and risk factors
- (2015) Chang-Fu Kuo et al. Nature Reviews Rheumatology
- Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature
- (2015) Anna Sironi et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Association Between Atrial Fibrillation and Dementia in the General Population
- (2015) Renée F. A. G. de Bruijn et al. JAMA Neurology
- The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
- (2015) James Crane et al. Therapeutic Advances in Chronic Disease
- Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity
- (2015) Jinan Chen et al. PLoS One
- Risk Factors That Affect Life Expectancy in Alzheimer's Disease: A 15-Year Follow-Up
- (2014) Carina Wattmo et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Mitochondrial target of thiazolidinediones
- (2014) J. R. Colca et al. DIABETES OBESITY & METABOLISM
- Latest treatment options for Alzheimer’s disease, Parkinson’s disease dementia and dementia with Lewy bodies
- (2014) Martin Broadstock et al. EXPERT OPINION ON PHARMACOTHERAPY
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
- (2014) Anna Secher et al. JOURNAL OF CLINICAL INVESTIGATION
- Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study
- (2014) Yi-Fang Chuang et al. NEUROBIOLOGY OF AGING
- Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males
- (2013) David E. Harrison et al. AGING CELL
- Calcium channel blockers and dementia
- (2013) V Nimmrich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Molecular mechanism of action of metformin: old or new insights?
- (2013) Graham Rena et al. DIABETOLOGIA
- Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease
- (2013) Renato Scacchi et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Diuretics
- (2013) George C. Roush et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial
- (2013) Alireza Esteghamati et al. REGULATORY PEPTIDES
- Treating Alzheimer’s disease with monoclonal antibodies: current status and outlook for the future
- (2013) Niels D Prins et al. Alzheimers Research & Therapy
- Heart disease as a risk factor for dementia
- (2013) Antoine Hakim et al. Clinical Epidemiology
- Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents α-Glucosidase inhibitors and their use in clinical practice
- (2012) Giuseppe Derosa et al. Archives of Medical Science
- Effectiveness of the Combination of Memantine Plus Vitamin D on Cognition in Patients With Alzheimer Disease
- (2012) Cédric Annweiler et al. Cognitive and Behavioral Neurology
- Statins and Cerebral Hemodynamics
- (2012) Sotirios Giannopoulos et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors
- (2012) S. L. Dickson et al. JOURNAL OF NEUROSCIENCE
- Exenatide Twice Daily: Analysis of Effectiveness and Safety Data Stratified by Age, Sex, Race, Duration of Diabetes, and Body Mass Index
- (2012) Richard Pencek et al. POSTGRADUATE MEDICINE
- Predictors of long-term cognitive outcome in Alzheimer's disease
- (2011) Carina Wattmo et al. Alzheimers Research & Therapy
- Mid-life and late-life vascular risk factors and dementia in Korean men and women
- (2010) H. Kimm et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of gender on response to treatment with rivastigmine in mild cognitive impairment: A post hoc statistical modeling approach
- (2009) Steven Ferris et al. Gender Medicine
- Antihypertensive drug therapy and blood pressure control in men and women: an international perspective
- (2009) M Thoenes et al. JOURNAL OF HUMAN HYPERTENSION
- Sex differences in obesity and the regulation of energy homeostasis
- (2009) J. C. Lovejoy et al. Obesity Reviews
- Gender Differences in Hypertension Treatment, Drug Utilization Patterns, and Blood Pressure Control Among US Adults With Hypertension: Data From the National Health and Nutrition Examination Survey 1999-2004
- (2008) Q. Gu et al. AMERICAN JOURNAL OF HYPERTENSION
- Efficacy of acetyl-cholinesterase-inhibitor (ACHEI) treatment in Alzheimer's disease: A 21-month follow-up “real world” study
- (2008) Marco Calabria et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Memantine protects rat cortical cultured neurons against β-amyloid-induced toxicity by attenuating tau phosphorylation
- (2008) M. S. Song et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Donepezil: potential neuroprotective and disease-modifying effects
- (2008) Sandra A Jacobson et al. Expert Opinion on Drug Metabolism & Toxicology
- The Effect of Age and Gender on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase
- (2008) Reza Khosravan et al. JOURNAL OF CLINICAL PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started